chevron_leftBack
As of 5 June 2026, Tibet Duo Rui Pharmaceutical Co., Ltd. has a market cap of $950.31M USD, ranking #11008 globally and #3126 in China.
It ranks #992 in the Healthcare sector, and #50 in the Drug Manufacturers - Specialty & Generic industry.
Key Stats
Market Cap
$950.31MUSD
6.43B CNY
Enterprise Value
$981.61MUSD
6.64B CNY
Revenue (TTM)
$22.78MUSD
154.18M CNY
EBITDA (TTM)
-$6.7MUSD
-45.36M CNY
Net Income (TTM)
-$15.1MUSD
-102.17M CNY
EBITDA Margin
-29%
Profit Margin
-66%
PS Ratio
41.7
PB Ratio
10.3
Company Profile
Country (HQ)
Sector
Healthcare
CEO
Yong Deng
open_in_new
Employees
497
Founded
2005
Website
duoruiyy.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 2.5% | 6.2% | 23% | 25% | 42% | 281% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
301075
西藏多瑞医药股份有限公司 Class A
ISIN: CNE100004RW5
Shares Out.:
Shares Outstanding:
78.956M1
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
83.45 CNY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Tibet Duo Rui Pharmaceutical Co., Ltd.
Tibet Duo Rui Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical pharmaceutical preparations, intermediates, and raw materials in China. It offers fluid therapy, anesthesiology medication, analgesic medication, and first-aid medication products, as well as sodium acetate ringer's injection; and agent products, such as amoxicillin sodium and clavulanate potassium for injection, etc. The company was founded in 2005 and is headquartered in Tibet, China.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
SHE: 002001
|
$15.86B
2K%
107.34B CNY
|
16.0
|
|
SHE: 002653
|
$9.1B
858%
61.6B CNY
|
80.6
|
|
SHE: 000423
|
$5.22B
449%
35.33B CNY
|
20.0
|
|
SHE: 002603
|
$4.21B
343%
28.47B CNY
|
20.8
|
|
SHE: 000623
|
$3.27B
244%
22.12B CNY
|
8.1
|
|
|
$2.74B
188%
18.55B CNY
|
11.5
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
TLV: TEVA
|
$37.93B
4K%
108.92B ILS
|
24.2
|
|
NASDAQ: RVMD
|
$29.56B
3K%
|
-
|
|
NSE: CIPLA
|
$11.11B
1K%
1.06T INR
|
23.4
|
|
NSE: LUPIN
|
$11.0B
1K%
1.05T INR
|
22.7
|
|
EPA: ABVX
|
$8.78B
823%
7.57B EUR
|
-
|
|
NSE: AUROPHARMA
|
$8.43B
787%
807.02B INR
|
23.1
|
chevron_leftBack